Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04646369 · ClinicalTrials.gov registry record · NA
Screening Wizard- Phase 2
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT04646369 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 100 participants.
The verdict
NCT04646369, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Screening Wizard (SW). Primary Care Providers (PCPs) are often uncertain about how to best refer adolescents who screen positive for depression or suicidality. Screen-positive youth who are either not in treatment, or express dissatisfaction with current treatment will be consented by an on-site research assistant (RA). Participants will answer questions via adaptive screens developed in a previous NIMH study (MH100155) for suicidal risk, anxiety, and mania. These will address perceived barriers and preferences about treatment. Participants are then randomized into 1 of 3 groups: 1) Providing the symptoms scores report of results to their provider based on their Screening Wizard responses (Screening as Usual); 2) Providing the symptoms scores report and their responses to treatment preferences and barriers including treatment recommendations their provider might suggest (Screening Wizard 2.0); or 3) Providing the report with treatment recommendations to their provider and a website called SOVA or Supporting Our Valued Adolescent, that is aimed at addressing perceptions about mental health providing support to teens through peer interaction that social workers and doctors moderate on a 24 hour a day basis (Screening Wizard 2.0 + SOVA).
Interventions
- BEHAVIORAL "screening as usual"
- BEHAVIORAL Screening Wizard 2.0
- BEHAVIORAL Screening Wizard 2.0 + SOVA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-11-05 |
| Est. Completion | 2021-09-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04646369
The ClinicalTrials.gov registry entry for NCT04646369 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which "screening as usual" is the first listed.
NCT04646369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04646369 about?
NCT04646369 is a clinical study titled "Screening Wizard- Phase 2". Screening Wizard (SW). Primary Care Providers (PCPs) are often uncertain about how to best refer adolescents who screen positive for depression or suicidality. Screen-positive youth who are either not in treatment, or express dissatisfaction with current treatment will be consented by an on-site res...
What is the current status of trial NCT04646369?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-11-05. Estimated completion is 2021-09-17.
What interventions are being tested in trial NCT04646369?
The interventions under investigation include: "screening as usual" (BEHAVIORAL), Screening Wizard 2.0 (BEHAVIORAL), Screening Wizard 2.0 + SOVA (BEHAVIORAL).
Who is sponsoring clinical trial NCT04646369?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.